Clinical aspects of pacients with chromoblastomycosis treated in a Dermatology Reference Center in the brazilian amazon
BACKGROUND: describes clinical aspects of patients with chromoblastomycosis treated at the dermatology department of the Para State University. The present study aimed to describe clinical and therapeutic aspects of patients with chromoblastomycosis treated at the dermatology department of Para State University.
METHODS: An observational, descriptive, case series study was performed, comprising 12 patients with the diagnosis of chromoblastomycosis. A clinical interview and a dermatological protocole were applied, classifing these patients in variables as gender, age, time of illness, type of lesion (size, shape, appearance, location and evolution), treatment and complications. Those unable to attend the clinic in person or unable to be represented by someone legally, a Term of Consent for Data Use was applied.
CONCLUSIONS: most of the patients were male, rural workers, with vegetative lesions according to the classification of Carrión, graduated as moderate, with less than 10 years of evolution.
2.Daboit, TC. Nanoemulsões de anfotericina B e itraconazol: avaliação da atividade antifúngica in vitro e in vivo em agentes da cromoblastomicose. 2013.Disponível:http://www.lume.ufrgs.br/bitstream/handle/10183/143339/000882701.pdf?sequence=1. Acessado em: 13 jan. 2016.
3.de Almeida, APM, et al. cromomicose: relato de caso e revisão da literatura. Rev Soc Bras Clin Med, v. 12, n. 1, p. 69-71, 2014.
4.Azad, K, et al. Cladophialophora carrionii: an aetiological agent of cutaneous chromoblastomycosis from a non‐endemic area, North India. Mycoses, v. 54, n. 4, p. e217-e219, 2012.
5.Martínez, RL; Tovar, LJM. Chromoblastomycosis. Clinics in dermatology, v. 25, n. 2, p. 188-194, 2007.
6.QUEIROZ-TELLES, F. CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE. Revista do Instituto de Medicina Tropical de São Paulo, v. 57, p. 46-50, 2015.
7.Carrión, AL. Chromoblastomycosis. Annals of the New York Academy of Sciences, v. 50, n. 10, p.
8. QUEIROZ-TELLES, F, et al. Subcutaneous mycoses. Infectious disease clinics of North America, v. 17, n. 1, p. 59-85, 2003.
9. QUEIROZ-TELLES, F, et al. Chromoblastomycosis. Clinical Microbiology Reviews, v. 30, n. 1, p. 233-276, 2017.
10.Ameen, M. Chromoblastomycosis: clinical presentation and management. Clinical and Experimental Dermatology, 34: 849–854. 2009. doi:10.1111/j.1365-2230.2009.03415.x
11.Pires CA, Simoes-Quaresma JA, Moraes-de Macedo GM, Brasil-Xavier M, Cardoso-de Brito A. Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region. Arch Med Res. 2013; 44:302-6
12. Matte SMW, Lopes JO, Melo IS, Espadim LER, Pinto MS. Cromoblastomicose no Rio Grande do Sul: Relato de 12 casos. Rev Soc Bras Med Trop. 1997;30:309-11
13.Minotto R, Bernardi CDV, Mallmann LF, Edelweiss MIA, Scroferneker ML. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul. J Am Acad Dermatol. 2001;44:585-92
14. Silva ACCM, Serra NA, Galväo CES, Marques SG, Saldanha ACR, Silva CMP, et al. Cromoblastomicose produzida por Fonsecaea pedrosoi no Estado do Maranhão: I - aspectos clínicos, epidemiológicos e evolutivos. Rev Soc Bras Med Trop. 1992;25:37-44.]
15. Bonifaz, A.; Carrasco‐Gerard, E.; Saul, A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses, v. 44, n. 1‐2, p. 1-7, 2001
16. Mouchalouat, MF. Cromoblastomicose. Estudo de uma série de 14 casos atendidos no Instituto de Pesquisa Clínica Evandro Chagas-Fundação Oswaldo Cruz, Rio de Janeiro, de 1994 a 2005. 2008. Tese de Doutorado. Instituto de Pesquisa Clínica Evandro Chagas.
17. SILVA, KLP, et al. Caracterização dos mecanismos de captação de ferro em Fonsecaea pedrosoi e Cladophialophora carrionii. 2017.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright policies & self-archiving
We are a RoMEO green journal.
Author's Pre-print: author can archive pre-print (ie pre-refereeing)
Author's Post-print: author can archive post-print (ie final draft post-refereeing)
Publisher's Version/PDF: author can archive publisher's version/PDF
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 4.0 License ©